ABEONA THERAPEUTICS INC (ABEO) Forecast, Price Target & Analyst Ratings

NASDAQ:ABEO • US00289Y2063

Current stock price

5.39 USD
-0.13 (-2.36%)
At close:
5.4 USD
+0.01 (+0.19%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ABEONA THERAPEUTICS INC (ABEO).

Forecast Snapshot

Consensus Price Target

Price Target
$19.96
+ 270.37% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
May 20, 2026
Period
Q1 / 2026
EPS Estimate
-$0.36
Revenue Estimate
4.663M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
86.67%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$19.96
Upside
+ 270.37%
From current price of $5.39 to mean target of $19.96, Based on 12 analyst forecasts
Low
$13.13
Median
$20.40
High
$29.40

Price Target Revisions

1 Month
-5.19%
3 Months
-5.19%

Price Target Summary

12 Wall Street analysts provided a forecast for the next 12 months for ABEO. The average price target is 19.96 USD. This implies a price increase of 270.37% is expected in the next year compared to the current price of 5.39.
The average price target has been revised downward by 5.19% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ABEO Current Analyst RatingABEO Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

ABEO Historical Analyst RatingsABEO Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
86.67%
ABEO was analyzed by 12 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about ABEO.
In the previous month the buy percentage consensus was at a similar level.
ABEO was analyzed by 12 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-03-19HC Wainwright & Co.Reiterate Buy -> Buy
2026-03-10HC Wainwright & Co.Reiterate Buy -> Buy
2025-10-13HC Wainwright & Co.Reiterate Buy -> Buy
2025-08-18HC Wainwright & Co.Reiterate Buy -> Buy
2025-08-15OppenheimerMaintains Outperform -> Outperform
2025-07-16HC Wainwright & Co.Reiterate Buy -> Buy
2025-07-14HC Wainwright & Co.Reiterate Buy -> Buy
2025-05-16StifelMaintains Buy -> Buy
2025-04-30HC Wainwright & Co.Maintains Buy -> Buy
2025-03-24HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-05OppenheimerInitiate Outperform
2025-02-19HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-25HC Wainwright & Co.Reiterate Buy -> Buy
2024-10-31HC Wainwright & Co.Reiterate Buy -> Buy
2024-10-29Cantor FitzgeraldReiterate Overweight -> Overweight
2024-09-20Cantor FitzgeraldReiterate Overweight -> Overweight
2024-08-14HC Wainwright & Co.Reiterate Buy -> Buy
2024-07-12HC Wainwright & Co.Reiterate Buy -> Buy
2024-07-03HC Wainwright & Co.Initiate Buy
2024-05-30StifelInitiate Buy
2024-05-16Cantor FitzgeraldMaintains Overweight -> Overweight
2024-04-23Cantor FitzgeraldReiterate Overweight -> Overweight
2023-08-24Cantor FitzgeraldReiterate Overweight -> Overweight
2023-07-13Cantor FitzgeraldReiterate Overweight -> Overweight
2023-05-24Alliance Global PartnersReiterate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 20, 2026
Period
Q1 / 2026
EPS Estimate
-$0.36
Revenue Estimate
4.663M
Revenue Q2Q
N/A
EPS Q2Q
-51.18%
Number of Analysts
9

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-75.51%
EPS (1 Month)
0.00%
EPS (3 Months)
-178.99%

Next Earnings Summary

ABEO is expected to report earnings on 5/20/2026. The consensus EPS estimate for the next earnings is -0.36 USD and the consensus revenue estimate is 4.66M USD.
The next earnings revenue estimate has been revised downward by 75.51% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2026 - 2033

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
ABEO revenue by date.ABEO revenue by date.
3.5M
148.23%
-100.00%		5.82M65.435M
1,024.31%		160.59M
145.42%		249.96M
55.65%		302.77M
21.13%		363.75M
20.14%		412.49M
13.40%		440.2M
6.72%		429.22M
-2.49%
EBITDA
YoY % growth
ABEO ebitda by date.ABEO ebitda by date.
-45.912M
-8.87%		-62.207M
-35.49%		-86.899M
-39.69%		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ABEO ebit by date.ABEO ebit by date.
-48.2M
-6.50%		-64.211M
-33.22%		-89.448M
-39.30%		-49.783M
44.34%		33.288M
166.87%		67.845M
103.81%		115.14M
69.71%		164.71M
43.05%		206.08M
25.12%		230.53M
11.86%		231.08M
0.24%
Operating Margin
ABEO operating margin by date.ABEO operating margin by date.
-1,377.14%N/A-1,536.91%-76.08%20.73%27.14%38.03%45.28%49.96%52.37%53.84%
EPS
YoY % growth
ABEO eps by date.ABEO eps by date.
-2.71
50.99%		-1.74
35.79%		-1.24
28.74%		-0.82
33.49%		0.20
123.85%		1.34
580.29%		2.24
67.68%		2.71
20.91%		3.54
30.45%		3.90
10.09%		4.07
4.45%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth		-0.36
-51.18%		-0.24
55.46%		-0.14
-36.98%		-0.09
76.76%		-0.14
61.58%		-0.06
72.64%		0.05
134.75%		0.14
266.09%
Revenue
Q2Q % growth		4.663M13.566M
3,291.50%		21.322M25.885M
377.58%		25.605M
449.11%		31.525M
132.38%		39.62M
85.82%		47.022M
81.66%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-20.925M
-6.07%		-13.527M
40.65%		-7.8M
67.53%		-6.496M
71.65%		-6.318M
69.81%		-463.08K
96.58%		8.758M
212.29%		14.166M
318.08%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ABEO Yearly Revenue VS EstimatesABEO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M 400M
ABEO Yearly EPS VS EstimatesABEO Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -10 -20 -30

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
45.48%
EPS Next 5 Year
33.17%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
250.93%
Revenue Next 5 Year
128.94%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ABEONA THERAPEUTICS INC / ABEO Forecast FAQ

Can you provide the average price target for ABEONA THERAPEUTICS INC stock?

12 analysts have analysed ABEO and the average price target is 19.96 USD. This implies a price increase of 270.37% is expected in the next year compared to the current price of 5.39.

Can you provide the upcoming earnings date for ABEONA THERAPEUTICS INC?

ABEONA THERAPEUTICS INC (ABEO) will report earnings on 2026-05-20.

What are the consensus estimates for ABEO stock next earnings?

The consensus EPS estimate for the next earnings of ABEONA THERAPEUTICS INC (ABEO) is -0.36 USD and the consensus revenue estimate is 4.66M USD.

Can you provide the consensus rating for ABEONA THERAPEUTICS INC stock?

The consensus rating for ABEONA THERAPEUTICS INC (ABEO) is 86.6667 / 100 . This indicates that analysts generally have a positive outlook on the stock.